Rockefeller Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $589K | Sell |
21,361
-54,235
| -72% | -$1.5M | ﹤0.01% | 1513 |
|
2025
Q1 | $2.14M | Buy |
75,596
+7,882
| +12% | +$223K | 0.01% | 1012 |
|
2024
Q4 | $2.82M | Sell |
67,714
-491
| -0.7% | -$20.5K | 0.01% | 888 |
|
2024
Q3 | $4.56M | Sell |
68,205
-108,516
| -61% | -$7.26M | 0.01% | 731 |
|
2024
Q2 | $21M | Buy |
176,721
+2,198
| +1% | +$261K | 0.06% | 304 |
|
2024
Q1 | $18.6M | Buy |
174,523
+4,465
| +3% | +$476K | 0.05% | 347 |
|
2023
Q4 | $16.9M | Buy |
170,058
+514
| +0.3% | +$51.1K | 0.06% | 325 |
|
2023
Q3 | $17.5M | Buy |
169,544
+10,895
| +7% | +$1.13M | 0.07% | 291 |
|
2023
Q2 | $19.3M | Buy |
158,649
+38,203
| +32% | +$4.64M | 0.07% | 277 |
|
2023
Q1 | $18.5M | Buy |
120,446
+1,962
| +2% | +$301K | 0.08% | 278 |
|
2022
Q4 | $21.3M | Buy |
118,484
+76,551
| +183% | +$13.7M | 0.11% | 213 |
|
2022
Q3 | $4.96M | Buy |
41,933
+4,000
| +11% | +$473K | 0.03% | 534 |
|
2022
Q2 | $5.42M | Buy |
37,933
+1,922
| +5% | +$274K | 0.03% | 500 |
|
2022
Q1 | $6.2M | Buy |
36,011
+12,222
| +51% | +$2.1M | 0.03% | 497 |
|
2021
Q4 | $6.04M | Buy |
23,789
+1,305
| +6% | +$331K | 0.03% | 488 |
|
2021
Q3 | $8.65M | Buy |
22,484
+3,043
| +16% | +$1.17M | 0.05% | 342 |
|
2021
Q2 | $4.57M | Sell |
19,441
-3,518
| -15% | -$826K | 0.03% | 475 |
|
2021
Q1 | $3.01M | Buy |
22,959
+1,810
| +9% | +$237K | 0.02% | 476 |
|
2020
Q4 | $2.21M | Sell |
21,149
-4,775
| -18% | -$499K | 0.02% | 499 |
|
2020
Q3 | $1.83M | Sell |
25,924
-4,138
| -14% | -$293K | 0.02% | 453 |
|
2020
Q2 | $1.93M | Sell |
30,062
-14,220
| -32% | -$913K | 0.02% | 397 |
|
2020
Q1 | $1.33M | Buy |
44,282
+44,100
| +24,231% | +$1.32M | 0.02% | 417 |
|
2019
Q4 | $4K | Buy |
182
+82
| +82% | +$1.8K | ﹤0.01% | 1824 |
|
2019
Q3 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1790 |
|